Cargando…

An arrhythmic episode after mercury exposure and successful treatment with chelation therapy: A case report

Detalles Bibliográficos
Autores principales:	Karakulak, Uğur Nadir, Gündüzüz, Meside, Tutkun, Engin, Yılmaz, Ömer Hınç
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kare Publishing 2015
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5337042/ https://www.ncbi.nlm.nih.gov/pubmed/26139172 http://dx.doi.org/10.5152/akd.2015.6282

Ejemplares similares

Evaluation of the ambulatory arterial stiffness index in lead-exposed workers
por: Karakulak, Uğur Nadir, et al.
Publicado: (2017)

Iron overload and fragmented QRS in patients with Thalassemia major: Mechanisms, therapies, and new horizons
por: Karakulak, Uğur Nadir, et al.
Publicado: (2015)

Assessment of the Cardiac Autonomic Nervous System in Mercury-Exposed Individuals via Post-Exercise Heart Rate Recovery
por: Yilmaz, Omer Hinc, et al.
Publicado: (2016)

Additional diagnostic parameter for coronary artery disease during exercise test: Heart rate recovery
por: Karakulak, Uğur Nadir, et al.
Publicado: (2015)

Serum endocan level and diastolic functions in the case of lead exposure
por: KARA, Halil, et al.
Publicado: (2019)

Can epicardial adipose tissue predict coronary artery plaque?
por: Yılmaz, Ömer Hinç, et al.
Publicado: (2015)

Possible changes of New-Generation inflammation markers with occupational lead exposure
por: Sipahi, Hande, et al.
Publicado: (2017)

Comparison of European Standard Patch Test Results of 330 Patients from an Occupational Diseases Hospital
por: Gündüz, Özge, et al.
Publicado: (2016)

A Mexican Standoff: Mitral stenosis, mitral balloon valvuloplasty, Tp-e interval, Tp-e/QT and Tp-e/QTc ratios and sympathetic activity
por: Karakulak, Uğur Nadir
Publicado: (2017)

Author’s Reply
por: Karakulak, Uğur Nadir
Publicado: (2016)

Diagnostic chelation challenge with DMSA: a biomarker of long-term mercury exposure?
por: Frumkin, H, et al.
Publicado: (2001)

A stranger in the heart
por: Karakulak, Uğur Nadir, et al.
Publicado: (2021)

A Stranger in the Heart Part 2: Recurrence
por: Yalçınkaya Öner, Damla, et al.
Publicado: (2023)

Reply to Letter to the Editor: “Recurrent Cardiac Myxoma: A Puzzle to be Solved”
por: Yalçınkaya Öner, Damla, et al.
Publicado: (2023)

Fourth Recurrence of Cardiac Myxoma in a Patient with Carney Complex
por: Yalçınkaya Öner, Damla, et al.
Publicado: (2023)

Squeezed Heart
por: Karakulak, Uğur Nadir, et al.
Publicado: (2015)

Novel Amperometric Mercury-Selective Sensor Based on Organic Chelator Ionophore
por: Elsebai, Basant, et al.
Publicado: (2023)

Mechanisms of pro-arrhythmic abnormalities in ventricular repolarisation and anti-arrhythmic therapies in human hypertrophic cardiomyopathy
por: Passini, Elisa, et al.
Publicado: (2016)

Risk stratifiers for arrhythmic and non-arrhythmic mortality after acute myocardial infarction
por: Gañán-Calvo, Alfonso M., et al.
Publicado: (2018)

The usefulness of chelation therapy for the remission of symptoms caused by previous treatment with mercury-containing pharmaceuticals: a case report
por: Corsello, Serafina, et al.
Publicado: (2009)

Omega-3 Fatty Acids: Anti-Arrhythmic, Pro-Arrhythmic, or Both?
por: von Schacky, C.
Publicado: (2012)

Dizygotic twin with congenital AV block
por: Karakulak, Uğur Nadir, et al.
Publicado: (2015)

Treatment of the arrhythmic storm
por: Grieco, Domenico, et al.
Publicado: (2019)

Chelation therapy after the Trial to Assess Chelation Therapy: results of a unique trial
por: Avila, Maria D., et al.
Publicado: (2014)

Decompression of the left heart chambers via atrial flow regulator: A new insight into heart failure treatment
por: Karakulak, Uğur Nadir, et al.
Publicado: (2021)

Mitochondrial Dysfunction Increases Arrhythmic Triggers and Substrates; Potential Anti-arrhythmic Pharmacological Targets
por: Saadeh, Khalil, et al.
Publicado: (2021)

A Review on Coordination Properties of Thiol-Containing Chelating Agents Towards Mercury, Cadmium, and Lead
por: Bjørklund, Geir, et al.
Publicado: (2019)

Rationale for the Successful Management of EDTA Chelation Therapy in Human Burden by Toxic Metals
por: Ferrero, Maria Elena
Publicado: (2016)

Pseudo-arrhythmic ECG Artifact
por: Singh, Satyajeet, et al.
Publicado: (2012)

An antibiotic recipe for an arrhythmic disaster
por: McCutcheon, Keir, et al.
Publicado: (2015)

All-trans Retinoic Acid–Induced Isolated Myocarditis: A Case Report and Review of the Literature
por: Karakulak, Ugur Nadir, et al.
Publicado: (2020)

Heavy metal chelator TPEN attenuates fura-2 fluorescence changes induced by cadmium, mercury and methylmercury
por: OHKUBO, Masato, et al.
Publicado: (2016)

Awareness of Asbestos and Action Plans for Its Exposure can Help Lives Exposed to Asbestos
por: Lee, Hu-Jang, et al.
Publicado: (2013)

Arrhythmic episodes in patients implanted with a cardioverter-defibrillator – results from the Prospective Study on Predictive Quality with Preferencing PainFree ATP therapies (4P)
por: Regoli, François, et al.
Publicado: (2019)

Comprehensive in vitro pro‐arrhythmic assays demonstrate that omecamtiv mecarbil has low pro‐arrhythmic risk
por: Qu, Yusheng, et al.
Publicado: (2021)

Propofol in ICU Settings: Understanding and Managing Anti-Arrhythmic, Pro-Arrhythmic Effects, and Propofol Infusion Syndrome
por: Paramsothy, Jananthan, et al.
Publicado: (2023)

Magico-religious mercury exposure.
por: Wendroff, A P
Publicado: (1997)

Biomarkers of Mercury Exposure in the Amazon
por: de Castro, Nathália Santos Serrão, et al.
Publicado: (2014)

Mercury Exposure and Heart Diseases
por: Genchi, Giuseppe, et al.
Publicado: (2017)

Evaluation of the potential role of chelation therapy in treatment of low to moderate lead exposures.
por: Chisolm, J J
Publicado: (1990)

Cannot write session to /tmp/vufind_sessions/sess_i06fshvsp9idp6pivnrm70e3ma